Motley Fool Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.03M Buy
15,794
+1,875
+13% +$835K 0.32% 62
2025
Q1
$6.75M Buy
13,919
+435
+3% +$211K 0.38% 58
2024
Q4
$5.43M Buy
13,484
+1,840
+16% +$741K 0.28% 74
2024
Q3
$5.47M Buy
11,644
+613
+6% +$288K 0.32% 73
2024
Q2
$5.2M Buy
11,031
+2,510
+29% +$1.18M 0.34% 69
2024
Q1
$3.56M Buy
8,521
+928
+12% +$388K 0.23% 86
2023
Q4
$3.09M Buy
7,593
+361
+5% +$147K 0.23% 86
2023
Q3
$2.51M Buy
7,232
+682
+10% +$237K 0.2% 89
2023
Q2
$2.31M Buy
+6,550
New +$2.31M 0.21% 86
2023
Q1
Sell
-6,303
Closed -$1.82M 203
2022
Q4
$1.82M Sell
6,303
-190
-3% -$54.9K 0.21% 86
2022
Q3
$1.88M Sell
6,493
-47
-0.7% -$13.6K 0.18% 90
2022
Q2
$1.89M Sell
6,540
-245
-4% -$70.8K 0.18% 95
2022
Q1
$1.77M Buy
6,785
+195
+3% +$50.9K 0.13% 110
2021
Q4
$1.45M Buy
6,590
+53
+0.8% +$11.6K 0.09% 123
2021
Q3
$1.19M Buy
6,537
+365
+6% +$66.2K 0.08% 135
2021
Q2
$1.24M Buy
6,172
+168
+3% +$33.9K 0.08% 130
2021
Q1
$1.29M Sell
6,004
-89
-1% -$19.1K 0.09% 120
2020
Q4
$1.44M Buy
6,093
+511
+9% +$121K 0.11% 109
2020
Q3
$1.53M Buy
5,582
+663
+13% +$181K 0.14% 97
2020
Q2
$1.43M Buy
4,919
+623
+15% +$181K 0.14% 90
2020
Q1
$1.02M Sell
4,296
-341
-7% -$81.1K 0.13% 102
2019
Q4
$1.02M Hold
4,637
0.11% 105
2019
Q3
$786K Buy
4,637
+362
+8% +$61.4K 0.09% 115
2019
Q2
$784K Buy
4,275
+322
+8% +$59.1K 0.09% 118
2019
Q1
$727K Buy
3,953
+854
+28% +$157K 0.08% 116
2018
Q4
$514K Buy
3,099
+294
+10% +$48.8K 0.07% 122
2018
Q3
$541K Buy
2,805
+130
+5% +$25.1K 0.07% 110
2018
Q2
$455K Buy
2,675
+420
+19% +$71.4K 0.06% 113
2018
Q1
$368K Buy
+2,255
New +$368K 0.05% 117